+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

2024-2029 Gonorrhea Molecular Diagnostics Market: USA, Europe, Japan - Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment - Hospitals, Commercial and Public Health Labs, POC Locations

  • PDF Icon

    Report

  • November 2024
  • Region: Europe, Japan, United States
  • VPG Market Research
  • ID: 5561781
Description Jump to:
This report presents test volumes, sale forecasts and supplier shares for the US, Europe (France, Germany, Italy, Spain, UK) and Japan. The report provides volume and sales forecasts for Gonorrhea tests performed in the following market segments:
  • Birth Centers
  • Commercial/Private Labs
  • Hospitals
  • Physician Offices
  • Public Health Labs
  • Surgery Centers
For each country, in addition to test volume and sales projections, includes sales and market share estimates for major suppliers of Gonorrhea tests.

Related Topics

Related Reports

2025 Rapid POC Infectious Disease Testing Market for 100 Major Tests: Supplier Shares and Strategies, Emerging Technologies--Physician Offices, Emergency Rooms, Ambulatory, Birth and Surgery Centers - Product Image

2025 Rapid POC Infectious Disease Testing Market for 100 Major Tests: Supplier Shares and Strategies, Emerging Technologies--Physician Offices, Emergency Rooms, Ambulatory, Birth and Surgery Centers

  • Report
  • Global
From
2025 US IVD Market Shares and Forecasts for 500 Blood Banking, Cancer, Chemistry, Coagulation, Drugs of Abuse, Endocrine, Flow Cytometry, Hematology, Immunodiagnostic, Immunoprotein, Infectious Diseases, Molecular Diagnostics, and TDM Tests - Product Image

2025 US IVD Market Shares and Forecasts for 500 Blood Banking, Cancer, Chemistry, Coagulation, Drugs of Abuse, Endocrine, Flow Cytometry, Hematology, Immunodiagnostic, Immunoprotein, Infectious Diseases, Molecular Diagnostics, and TDM Tests

  • Report
  • United States
From
Sexually Transmitted Diseases Diagnostics Market - Global Forecast 2025-2032 - Product Image

Sexually Transmitted Diseases Diagnostics Market - Global Forecast 2025-2032

  • Report
  • 188 Pages
  • Global
From
Sexually Transmitted Disease (STD) Testing Market - Forecast from 2026 to 2031 - Product Image

Sexually Transmitted Disease (STD) Testing Market - Forecast from 2026 to 2031

  • Report
  • 149 Pages
  • Global
From
Point of Care Diagnostics Market Report by Products, Technology, Point of prescription, End-User, Countries and Company Analysis 2026-2034 - Product Image

Point of Care Diagnostics Market Report by Products, Technology, Point of prescription, End-User, Countries and Company Analysis 2026-2034

  • Report
  • 200 Pages
  • Global
From

About the Gonorrhea Molecular Diagnostics Market

Molecular Diagnostics is a type of medical testing that uses molecular biology techniques to detect and diagnose diseases. Molecular Diagnostics is used to detect and identify genetic material, such as DNA and RNA, in order to diagnose and monitor diseases. Gonorrhea Molecular Diagnostics is a type of Molecular Diagnostics used to detect and diagnose gonorrhea, a sexually transmitted infection caused by the bacterium Neisseria gonorrhoeae. Gonorrhea Molecular Diagnostics tests are used to detect the presence of the bacterium in a patient's sample. These tests can be used to diagnose gonorrhea in both men and women, and can be used to detect the presence of antibiotic-resistant strains of the bacterium. Molecular Diagnostics tests for gonorrhea are often used in combination with other tests, such as urine tests, to confirm a diagnosis. Companies in the Gonorrhea Molecular Diagnostics market include Roche Diagnostics, Abbott Laboratories, Becton Dickinson, Cepheid, Hologic, and Qiagen. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.